LIPOCUBE BIO TECHNOLOGY LIMITEDActive

Company number 11058540Private limited companyIncorporated 2017
⚠ Confirmation statement overdue. It was due on 20 Oct 2026.

Key figures

£391,269-21.4%
Net assets 2025
+24.4%
Average annual growth 2020–2025
0200 k400 k600 k202020212022202320242025

Like most small UK companies, LIPOCUBE BIO TECHNOLOGY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m202020212022202320242025
Filed accounts2020–2025
20212022202320242025
Cash at bank and in hand35134,13412,6797071,142
Total assets168,289282,072915,232190,2382,095,464
Total liabilities——342,414472,3151,704,195
Net assets / total equity130,137128,820572,818497,676391,269
Average number of employees22000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: LIPOCUBE BIO TECHNOLOGY LIMITED

Company

LIPOCUBE BIO TECHNOLOGY LIMITED is a private limited company registered with Companies House under company number 11058540. It was incorporated on 10 Nov 2017. Its status is active. The registered office is in Sheffield (S3). Its nature of business (SIC 2007) is retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749), research and experimental development on biotechnology (72110), specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £391,269, down 21.4% on the previous year. Cash at bank and in hand was £1,142. Total assets were £2,095,464 and total liabilities £1,704,195. The company had an average of 0 employees. Figures are available for 6 financial years (2020–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 20 Oct 2026.